CDH1 and prostate carcinoma: In prostate cancer cells, E-cadherin is mainly post-transcriptionally regulated wherein autocrine EGFR activation leads to catenin phosphorylation and junctional complexes instability and subsequent E-cadherin internalization and degradation [8, 28].